Clinical Trial: Special Drug Use Investigation for VALTREX (Valaciclovir) (Suppression Prophylaxis)

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

Official Title: Special Drug Use Investigation for VALTREX (Valaciclovir) (Suppression Prophylaxis)

Brief Summary: The purpose of this study is to collect and assess information on proper use of valaciclovir regarding safety and efficacy of long-term use in suppressive therapy for subjects with recurrent genital herpes.

Detailed Summary:
Sponsor: GlaxoSmithKline

Current Primary Outcome: The number of adverse events in Japanese subjects with recurrent genital herpes treated with valaciclovir [ Time Frame: 1 year ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: GlaxoSmithKline

Dates:
Date Received: July 7, 2011
Date Started: November 2006
Date Completion:
Last Updated: May 15, 2017
Last Verified: May 2017